IQVIA Exceeds Expectations With Robust Q3 Results; Raising FVE to $276 on Improved Near-Term Outlook

IQVIA (formerly QuintilesIMS) is the result of the merger of Quintiles, a leading late-stage contract research organization, and IMS Health, a dominant player in life sciences data and analytics. The combined company has become an established leader in both the CRO space and life sciences data and analytics. Further, as a result of the merger, the company leads in real-world evidence, in which data from sources such as patient records or medical claims can be used to create clinical evidence for regulatory approval.